Ignite Creation Date:
2024-07-17 @ 11:15 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06472830
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-06-25
First Post:
2024-06-19
Brief Title:
Monoclonal Gammopathy of Undetermined Significance MGUS Multiple Myeloma MM Awareness and Genetic Insights Campaign
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Monoclonal Gammopathy of Undetermined Significance MGUS Myeloma Awareness and Genetic Insights Campaign MAGIC Screening Study
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MAGIC
Brief Summary:
This study is being done to screen for monoclonal gammopathies in people of East African descent Monoclonal gammopathy is a condition where abnormal proteins are found in the blood most commonly called monoclonal gammopathy of undetermined significance or MGUS There is little information on the presence of this condition in people of East African descent This study is being done to determine how this condition affects this population in order to better treat andor prevent this condition in the future
Detailed Description:
PRIMARY OBJECTIVE
I To determine the prevalence of MGUS in people of East African descent in Minnesota
OUTLINE This is an observational study
Participants undergo medical chart review and blood sample collection as well as complete a questionnaire on study Participants who test positive for MGUS are notified along with their primary care physician so that the necessary follow up and referral is provided as clinically indicated
I To determine the prevalence of MGUS in people of East African descent in Minnesota
OUTLINE This is an observational study
Participants undergo medical chart review and blood sample collection as well as complete a questionnaire on study Participants who test positive for MGUS are notified along with their primary care physician so that the necessary follow up and referral is provided as clinically indicated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-04825 | REGISTRY | None | None |
| 23-008956 | OTHER | None | None |